Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Kyocera to expand...

    Kyocera to expand medical product development

    Written by supriya kashyap kashyap Published On 2017-09-27T09:16:03+05:30  |  Updated On 18 Aug 2021 12:25 PM IST

    Tokyo: Kyocera Corporation announced plans to expand operations at its new Medical Development Center which opened in Japan's Shiga Prefecture at the company's Shiga Yasu Plant in April 2017.


    The new Medical Development Center integrates medical product manufacturing and R&D operations for Kyocera to aid in future innovations such as wearable and implantable devices.


    The Kyocera Group offers a wide range of products and services in the medical sector including orthopedic/dental implants and electronic components for medical devices. To maximize synergies in device-related businesses, Kyocera Medical Corporation, a former wholly owned subsidiary, was merged into Kyocera Corporation in April this year.


    As part of the consolidation, Kyocera is currently combining three Japan-based manufacturing operations for medical devices into the Shiga Yasu Plant and additionally established the Medical Development Center which integrates R&D activities. Through the integration, the company aims to unify manufacturing and R&D operations, and expand business in health and medical markets in a speedy manner.


    The company is increasing the development team and accelerating the development of medical products such as wearable and implantable devices by leveraging its expertise as a producer of components. Recent Kyocera developments include a miniaturized blood-flow sensor as well as earbuds with this sensor build in. With the earbuds, the company is developing applications such as monitoring health conditions while listening to music and is also promoting the development of new devices utilizing the blood-flow sensor.


    The company is also engaged in a collaborative project with Kyoto University and Osaka University to develop a new cochlear implant. Furthermore, Kyocera Communication Systems Co., Ltd. a subsidiary which offers information and communications technology (ICT) solutions - recently launched a joint research with the University of Tsukuba to develop an Artificial Intelligence (AI) system capable of detecting skin diseases by analyzing digital images of a patient's skin. Through these projects, the Kyocera Group aims to create various new businesses in the health and medical field.


    AIartificial intelligenceKyoceraKyoto UniversityMedical Development Centermedical productOsaka UniversityShiga Yasu Plant
    Source : ANI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    supriya kashyap kashyap
    supriya kashyap kashyap
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok